Chong Kun Dang Pharmaceutical Corp. - Company Profile
Powered by
All the data and insights you need on Chong Kun Dang Pharmaceutical Corp. in one report.
- Save hours of research time and resources with
our up-to-date Chong Kun Dang Pharmaceutical Corp. Strategy Report
- Understand Chong Kun Dang Pharmaceutical Corp. position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Chong Kun Dang Pharmaceutical Corp (CKD Pharma), manufactures, distributes, imports and exports prescription drugs, OTC drugs, health supplements and consumer health products. The company works following therapeutic areas such as oncology, neurology and immunology and others. Its product portfolio includes prescription products for the entire segment and therapeutic classes; vitamins; shampoos; hair colours; aerosols; mat vaporizers and mosquito coils; and others. The company’s Chong Kun Dang Research Institute is characterized by three independent laboratories, namely, The New Drug Discovery Labs, The Technology Development Labs; and the Bio Research Labs. It has a manufacturing facility in Cheonan City, South Korea. CKD Pharma is headquartered in Seoul, South Korea.
Chong Kun Dang Pharmaceutical Corp. premium industry data and analytics
Products and Services
Products | Brands |
---|---|
- | Liquistal |
Prescription Drugs | Duvie |
Over the Counter Products | Camptobell |
XYZ | XYZ |
XYZ | XYZ |
XYZ | XYZ |
Competitor Comparison
Key Parameters | Chong Kun Dang Pharmaceutical Corp. | Daewoong Pharmaceutical Co Ltd | Dong-A Socio Holdings Co Ltd | Ildong Pharmaceutical Co Ltd | Suheung Capsule Co Ltd |
---|---|---|---|---|---|
Headquarters | South Korea | South Korea | South Korea | South Korea | South Korea |
City | Seoul | Hwaseong | Seoul | Seoul | Cheongju |
No. of Employees | 1,904 | 1,256 | 273 | 1,433 | 727 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Young-Joo Kim | President; Chief Executive Officer | Senior Management | 2021 | - |
Kim Seong-gon | Director | Non Executive Board | - | - |
Kang In-Soo | Director | Non Executive Board | 2019 | - |
Chang Dong-shin | Director | Non Executive Board | 2022 | - |
Jamin Gu | Director | Non Executive Board | - | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward